Page 3 - Collection Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

For bringing it down which violated canadian air space. efforts are underway off the coast of south carolina to successfully recover and retrieve what's left of the payload that balloon was carrying. kerry, i know you worked as an attorney. your reaction to all of this. how this went down and how much of a security risk do you think this posed? or is this more of an intelligence risk i suppose. >> i think what we're seeing, what's so interesting about this particular story is that we're seeing intelligence activities spilled out into the open, presuming this balloon is not a meteorological pie...

UCR's Office of Research and Economic Development (RED) has announced over $1.7 million in competitive funding for faculty research projects through its Opportunity to Advance Sustainability Innovation and Social Inclusion initiative, known as OASIS. The projects range from probing the severity of COVID-19 infection in Riverside County, through sustainability and resilience in agriculture; to finding ways to mine lithium needed for electric car batteries from brine below the Salton Sea.

Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic™ Collection Device focus

But the statement we received from the u.s. embassy there did not specify anything really. all they said was they received a report of this anomalous health incident and out of an abundance of caution they delayed the vice president's trip there. >> i know you've been covering this sometime. no definitive answers, but to date when u.s. officials you speak with talk about a most likely culprit, they say? >> they say russia. russia is the most likely culprit at this point. they have been testing these kind of directed energy weapons for years now. they have motive obviously. but the intel commun...

NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that its major subsidiary, Lucid Diagnostics Inc. (“Lucid”), has completed European IVDD CE Mark certification of its EsoGuard® Esophageal DNA Test (“EsoGuard”). Lucid and its EU authorized representative completed the EC declaration of conformity procedure, including the associated technical documentation, ensu